Oddity initiated with a Buy at Jefferies

Jefferies initiated coverage of Oddity (ODD) with a Buy rating and $78 price target The company has a record of growing brands organically, which will translate to success with its Q4 launch of its third brand, a medical-grade skincare, the analyst tells investors in a research note. The firm also expects continued growth in Oddity’s IL MAKIAGE and SpoiledChild lines. It believes the stock is undervalued relative the company’s growth outlook.